Engers R, Mueller M, Walter A, Collard J G, Willers R, Gabbert H E
Institute of Pathology, Heinrich-Heine-University, Moorenstrasse 5, Duesseldorf D-40225, Germany.
Br J Cancer. 2006 Oct 23;95(8):1081-6. doi: 10.1038/sj.bjc.6603385. Epub 2006 Sep 26.
The Rac-specific guanine nucleotide exchange factor, Tiam1, plays a major role in oncogenicity, tumour invasion and metastasis but its usefulness as a prognostic marker in human cancer has not been tested yet. In the present study, Tiam1 expression was analysed in benign secretory epithelium, pre-neoplastic high-grade prostatic intraepithelium neoplasia (HG-PIN) and prostate carcinomas of 60 R0-resected radical prostatectomy specimens by semiquantitative immunohistochemistry. Tiam1 proved significantly overexpressed in both HG-PIN (P<0.001) and prostate carcinomas (P<0.001) when compared to benign secretory epithelium. Strong Tiam1 overexpression (i.e. > or =3.5-fold) in prostate carcinomas relative to the respective benign prostatic epithelium was statistically significantly associated with disease recurrence (P=0.016), the presence of lymph vessel invasion (P=0.031) and high Gleason scores (GS) (i.e. > or =7) (P=0.044). Univariate analysis showed a statistically significant association of strong Tiam1 overexpression with decreased disease-free survival (DFS) (P=0.03). This prognostic effect of strong Tiam1 overexpression remained significant in multivariate analysis including preoperative prostate-specific antigen levels, pT stage, and GS (relative risk= 3.75, 95% confidence interval=1.06-13.16; P=0.04). Together, our data suggest that strong Tiam1 overexpression relative to the corresponding benign epithelial cells is a new and independent predictor of decreased DFS for patients with prostate cancer.
Rac特异性鸟嘌呤核苷酸交换因子Tiam1在致癌性、肿瘤侵袭和转移中起主要作用,但尚未在人类癌症中作为预后标志物进行检验。在本研究中,通过半定量免疫组织化学分析了60例R0切除的根治性前列腺切除术标本的良性分泌上皮、癌前高级别前列腺上皮内瘤变(HG-PIN)和前列腺癌中的Tiam1表达。与良性分泌上皮相比,Tiam1在HG-PIN(P<0.001)和前列腺癌(P<0.001)中均显著过表达。前列腺癌中Tiam1相对于相应良性前列腺上皮的强过表达(即≥3.5倍)与疾病复发(P=0.016)、淋巴管浸润(P=0.031)和高Gleason评分(GS)(即≥7)(P=0.044)在统计学上显著相关。单因素分析显示,Tiam1强过表达与无病生存期(DFS)降低在统计学上显著相关(P=0.03)。在包括术前前列腺特异性抗原水平、pT分期和GS的多因素分析中,Tiam1强过表达的这种预后作用仍然显著(相对风险=3.75,95%置信区间=1.06-13.16;P=0.04)。总之,我们的数据表明,相对于相应的良性上皮细胞,Tiam1强过表达是前列腺癌患者DFS降低的一个新的独立预测因子。